Peritoneal Dialysis Market by Offering (Peritoneal Dialysis Solution Bags, Machines), Modality (Continuous Ambulatory Peritoneal Dialysis Center(CAPD)), Disease Indication (End-Stage Renal Disease), End User (Hospitals) - Global Forecast to 2029
The peritoneal dialysis market is projected to reach USD 12.70 Billion by 2029 from USD 9.58 Billion in 2024 at a CAGR of 5.8% during the forecast period. Favorable healthcare policies in developed markets have highly increased access to peritoneal dialysis since many now offer reimbursements for home-based dialysis treatments. In most cases, the United States, Canada, and several others in Europe have come up with policies that acknowledge the cost-effectiveness and better benefits for patients through peritoneal dialysis over in-center hemodialysis. Such policies reduce the barriers associated with the cost of treatment by establishing reimbursement coverage for a significant portion of the PD-associated treatment costs. This could make PD a much more affordable and accessible form of therapy for patients, and reimbursement programs promote the practice of healthcare providers to recommend PD due to its flexibility and practicality, also for those preferring home management of treatment. For instance, in the United States, Medicare's ESRD program encourages wider adoption by providing reimbursements for home dialysis. Likewise, other developed markets also are following and encouraging home dialysis since it reduces hospital admissions, improves patient outcomes, and reduces burdens on the healthcare facilities. The financial support that comes with PD has become a reason for the aged and bedridden patients who have been able to live better as a result of reduced immobilization and enhanced personal care.
“The peritoneal solution bags segment is accounted for the largest share of peritoneal dialysis market.”
Peritoneal dialysis solution bags are less expensive than machines because they are not reliant upon pricey technology and maintenance. Because of this, these bags are very inexpensive for patients and healthcare systems, whose production and distribution costs make it possible to sell these bags at prices within everyone's reach, especially in countries that have tightly constrained health care budgets. Solution bags also reduce the requirement for costly equipment and training of the staff, thereby reducing the overall cost of treatment. This adds to the attractiveness of solution bags as a treatment option for a larger number of patients in resource-poor settings for access to necessary dialysis.
“Continuous Ambulatory Peritoneal Dialysis (CAPD) segment holds the largest market share of peritoneal dialysis market.”
The increased coverage of CAPD supplies, especially the solution bags, has stimulated its adoption, especially in developing countries. CAPD, being any form of dialysis treatment, requires only basic supplies, like solution bags, and hence is much simpler to distribute and implement in areas with very poor healthcare resources than expensive machinery. Therefore, it is more cost-effective and accessible to patients in low-resource settings as a practically offered form of dialysis. Ease of use and minimization of the use of hospital facilities further increase the adoption rate of CAPD, thereby increasing access to dialysis care in underprivileged areas globally.
“End-stage renal disease segment holds the largest market share in the global peritoneal dialysis market and expected to grow at the highest CAGR during the forecast period”
Most healthcare systems promote home dialysis options to decrease the prevalence of hospital visits attributed to end-stage renal disease (ESRD), which subsequently saves the overall cost of healthcare. Health care providers would benefit from home peritoneal dialysis by reducing the need for in-center dialysis, thus saving hospital facility capacities and minimizing the problems it poses both to facilities and personnel. Home dialysis will also improve patients' lives as they assume control over their treatment. An added advantage of home-based PD is that it is very economical since it saves transportation costs, it minimizes the susceptibility to infection, and encourages continuity of care, which makes it an attractive modality for health care systems.
“Home care setttings segment accounted for the largest market share in the global peritoneal dialysis market and expected to grow at the highest CAGR during the forecast period.”
Portable and user-friendly dialysis equipment have further improved the safety and ease of treatment in the home setting for patients. Modern peritoneal dialysis machines are well designed with intuitive interfaces, automation, and compact size, making them devices that patients can use with relative ease, without relying so much on medical knowledge. Thus, independent and comfortable home-based dialysis has reduced a patient's dependence on healthcare professionals. Safety measures have upgraded with live monitoring and automatic alarms that enhanced outcomes best dealt with early before dangers occur. In those innovations, patient confidence in handling their care improved, while the treatment compliance was generally enhanced.
“North America to witness the substantial growth rate during the forecast period.”
The peritoneal dialysis market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa and GCC Countries based on the region type. In 2023, the Asia Pacific region is projected to exhibit the highest CAGR during the forecast period. However, North America accounts for the largest market share of the peritoneal dialysis market in 2023. North America is the largest regional market for global peritoneal dialysis, and this is partly because healthcare providers in this region have been trained specifically to manage this treatment. This places them in a better position to ensure that patients requiring the treatment receive a holistic education on how to carry out procedures safely and effectively at home. Moreover, these professionals provide timely interventions through effective monitoring, thus making the outcomes better as well as complications as low as possible. Specialized training programs and ongoing professional development in the region further underpin quality care. Such professionalism among healthcare professionals has indeed contributed to success in the introduction and spread of peritoneal dialysis in North America.
A breakdown of the primary participants (supply-side) for the peritoneal dialysis market referred to for this report is provided below:
Research Coverage:
The market study covers the peritoneal dialysis market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by offering, modality, disease indication, end user and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
? Analysis of Market Dynamics: Drivers (rising prevalence of chronic kidney diseases, growing prevalence of diabetes and hypertension, and technological advancements and increased investment in R&D) restraints (underutilization of peritoneal dialysis in low-income and lower-middle-income countries (LLMICs)) opportunities (increasing growth opportunities in emerging economies, and surge in demand for home dialysis treatment), and challenges (growing incidence of treated kidney failure, and shortage of skilled nephrologists in low-income and lower-middle-income countries (LLMICs))
? Services/Innovations: Detailed insights on upcoming technologies, research & development activities, and new product launches in the peritoneal dialysis market.
? Market Development: Comprehensive information on the lucrative emerging markets, components, demographics, end-user, and region.
? Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the peritoneal dialysis market.
? Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the peritoneal dialysis market like Baxter International Inc. (US), Fresenius Medical Care AG (Germany), Medtronic plc (Ireland), Davita Inc. (US), Becton, Dickinson and Company (US).
“The peritoneal solution bags segment is accounted for the largest share of peritoneal dialysis market.”
Peritoneal dialysis solution bags are less expensive than machines because they are not reliant upon pricey technology and maintenance. Because of this, these bags are very inexpensive for patients and healthcare systems, whose production and distribution costs make it possible to sell these bags at prices within everyone's reach, especially in countries that have tightly constrained health care budgets. Solution bags also reduce the requirement for costly equipment and training of the staff, thereby reducing the overall cost of treatment. This adds to the attractiveness of solution bags as a treatment option for a larger number of patients in resource-poor settings for access to necessary dialysis.
“Continuous Ambulatory Peritoneal Dialysis (CAPD) segment holds the largest market share of peritoneal dialysis market.”
The increased coverage of CAPD supplies, especially the solution bags, has stimulated its adoption, especially in developing countries. CAPD, being any form of dialysis treatment, requires only basic supplies, like solution bags, and hence is much simpler to distribute and implement in areas with very poor healthcare resources than expensive machinery. Therefore, it is more cost-effective and accessible to patients in low-resource settings as a practically offered form of dialysis. Ease of use and minimization of the use of hospital facilities further increase the adoption rate of CAPD, thereby increasing access to dialysis care in underprivileged areas globally.
“End-stage renal disease segment holds the largest market share in the global peritoneal dialysis market and expected to grow at the highest CAGR during the forecast period”
Most healthcare systems promote home dialysis options to decrease the prevalence of hospital visits attributed to end-stage renal disease (ESRD), which subsequently saves the overall cost of healthcare. Health care providers would benefit from home peritoneal dialysis by reducing the need for in-center dialysis, thus saving hospital facility capacities and minimizing the problems it poses both to facilities and personnel. Home dialysis will also improve patients' lives as they assume control over their treatment. An added advantage of home-based PD is that it is very economical since it saves transportation costs, it minimizes the susceptibility to infection, and encourages continuity of care, which makes it an attractive modality for health care systems.
“Home care setttings segment accounted for the largest market share in the global peritoneal dialysis market and expected to grow at the highest CAGR during the forecast period.”
Portable and user-friendly dialysis equipment have further improved the safety and ease of treatment in the home setting for patients. Modern peritoneal dialysis machines are well designed with intuitive interfaces, automation, and compact size, making them devices that patients can use with relative ease, without relying so much on medical knowledge. Thus, independent and comfortable home-based dialysis has reduced a patient's dependence on healthcare professionals. Safety measures have upgraded with live monitoring and automatic alarms that enhanced outcomes best dealt with early before dangers occur. In those innovations, patient confidence in handling their care improved, while the treatment compliance was generally enhanced.
“North America to witness the substantial growth rate during the forecast period.”
The peritoneal dialysis market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa and GCC Countries based on the region type. In 2023, the Asia Pacific region is projected to exhibit the highest CAGR during the forecast period. However, North America accounts for the largest market share of the peritoneal dialysis market in 2023. North America is the largest regional market for global peritoneal dialysis, and this is partly because healthcare providers in this region have been trained specifically to manage this treatment. This places them in a better position to ensure that patients requiring the treatment receive a holistic education on how to carry out procedures safely and effectively at home. Moreover, these professionals provide timely interventions through effective monitoring, thus making the outcomes better as well as complications as low as possible. Specialized training programs and ongoing professional development in the region further underpin quality care. Such professionalism among healthcare professionals has indeed contributed to success in the introduction and spread of peritoneal dialysis in North America.
A breakdown of the primary participants (supply-side) for the peritoneal dialysis market referred to for this report is provided below:
- By Company Type: Tier 1–45%, Tier 2–30%, and Tier 3–25%
- By Designation: C-level–35%, Director Level–25%, and Others–40%
- By Region: North America–40%, Europe–20%, Asia Pacific–25%, Latin America- 10%, and Middle East and Africa– 3% and GCC Countries– 2%
Research Coverage:
The market study covers the peritoneal dialysis market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by offering, modality, disease indication, end user and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
? Analysis of Market Dynamics: Drivers (rising prevalence of chronic kidney diseases, growing prevalence of diabetes and hypertension, and technological advancements and increased investment in R&D) restraints (underutilization of peritoneal dialysis in low-income and lower-middle-income countries (LLMICs)) opportunities (increasing growth opportunities in emerging economies, and surge in demand for home dialysis treatment), and challenges (growing incidence of treated kidney failure, and shortage of skilled nephrologists in low-income and lower-middle-income countries (LLMICs))
? Services/Innovations: Detailed insights on upcoming technologies, research & development activities, and new product launches in the peritoneal dialysis market.
? Market Development: Comprehensive information on the lucrative emerging markets, components, demographics, end-user, and region.
? Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the peritoneal dialysis market.
? Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the peritoneal dialysis market like Baxter International Inc. (US), Fresenius Medical Care AG (Germany), Medtronic plc (Ireland), Davita Inc. (US), Becton, Dickinson and Company (US).
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 IMPACT OF AI/GEN AI
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.2 MARKET SIZE ESTIMATION
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
2.2.3 USAGE-BASED MARKET ESTIMATION
2.2.4 PRIMARY RESEARCH VALIDATION
2.3 GROWTH FORECAST ESTIMATION
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PERITONEAL DIALYSIS MARKET OVERVIEW
4.2 ASIA PACIFIC: PERITONEAL DIALYSIS MARKET, BY OFFERING (2023)
4.3 PERITONEAL DIALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 REGIONAL MIX: PERITONEAL DIALYSIS MARKET (2024?2029)
4.5 PERITONEAL DIALYSIS MARKET: DEVELOPED VS. DEVELOPING ECONOMIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of chronic kidney diseases
5.2.1.2 Growing prevalence of diabetes and hypertension
5.2.1.3 Technological advancements and increased investment in R&D
5.2.2 RESTRAINTS
5.2.2.1 Underutilization of peritoneal dialysis in low-income and lower-middle-income countries (LLMICs)
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing growth opportunities in emerging economies
5.2.3.2 Surge in demand for home dialysis treatment
5.2.4 CHALLENGES
5.2.4.1 Shortage of skilled nephrologists in low-income and lower-middle-income countries (LLMICs)
5.2.4.2 High risk of peritonitis as a barrier to peritoneal dialysis adoption
5.3 INDUSTRY TRENDS
5.3.1 INCREASED ADOPTION OF HOME-BASED TREATMENTS
5.3.2 RISING INCIDENCE OF CHRONIC KIDNEY DISEASE (CKD)
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 Automated peritoneal dialysis (APD) machines
5.4.2 COMPLEMENTARY TECHNOLOGIES
5.4.2.1 Remote monitoring systems
5.4.3 ADJACENT TECHNOLOGIES
5.4.3.1 Wearable technology
5.5 SUPPLY CHAIN ANALYSIS
5.6 VALUE CHAIN ANALYSIS
5.7 TRADE ANALYSIS
5.7.1 TRADE ANALYSIS FOR PERITONEAL DIALYSIS MACHINES, SOLUTION BAGS, CATHETERS, AND TRANSFER SETS (HS CODE 9018)
5.8 PORTER’S FIVE FORCES ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF SUPPLIERS
5.8.4 BARGAINING POWER OF BUYERS
5.8.5 INTENSITY OF COMPETITIVE RIVALRY
5.9 REGULATORY ANALYSIS
5.9.1 REGULATORY LANDSCAPE
5.9.1.1 North America
5.9.1.1.1 US
5.9.1.1.2 Canada
5.9.1.2 Europe
5.9.1.3 Asia Pacific
5.9.1.3.1 India
5.9.1.3.2 China
5.9.1.3.3 Japan
5.9.1.3.4 South Korea
5.9.1.4 Latin America
5.9.1.4.1 Brazil
5.9.1.4.2 Mexico
5.9.1.5 Middle East
5.9.1.6 Africa
5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.10 PATENT ANALYSIS
5.10.1 PATENT PUBLICATION TRENDS FOR PERITONEAL DIALYSIS MARKET
5.10.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.11 PRICING ANALYSIS
5.11.1 AVERAGE SELLING PRICE OF PERITONEAL DIALYSIS PRODUCTS AND CONSUMABLES, BY KEY PLAYER (2023)
5.12 KEY CONFERENCES & EVENTS, 2024–2025
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2 KEY BUYING CRITERIA
5.14 ECOSYSTEM ANALYSIS
5.15 ADJACENT MARKET ANALYSIS
5.15.1 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
5.15.2 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET
5.16 CASE STUDY ANALYSIS
5.17 IMPACT OF GENERATIVE AI ON PERITONEAL DIALYSIS MARKET
5.18 UNMET NEEDS AND END-USER EXPECTATIONS
5.19 TRENDS/DISRUPTIONS AFFECTING CUSTOMERS’ BUSINESSES
5.20 INVESTMENT & FUNDING SCENARIO
5.21 PROCEDURE DATA ANALYSIS
5.21.1 PREVALENCE DATA FOR TREATED KIDNEY FAILURE
6 PERITONEAL DIALYSIS MARKET, BY OFFERING
6.1 INTRODUCTION
6.2 PERITONEAL DIALYSIS PRODUCTS
6.2.1 PERITONEAL DIALYSIS SOLUTION BAGS
6.2.1.1 High demand for solutions to boost segmental growth
6.2.2 PERITONEAL DIALYSIS MACHINES
6.2.2.1 Rising prevalence of chronic diseases in emerging economies to boost adoption
6.2.3 PERITONEAL DIALYSIS CATHETERS
6.2.3.1 Favorable reimbursement policies to support market growth
6.2.4 PERITONEAL DIALYSIS TRANSFER SETS
6.2.4.1 Product recalls to limit market growth
6.2.5 OTHER PERITONEAL DIALYSIS PRODUCTS
6.3 PERITONEAL DIALYSIS SERVICES
6.3.1 BETTER PRIVACY AND INCREASED COMFORT OF AT-HOME DIALYSIS TREATMENT TO DRIVE MARKET
7 PERITONEAL DIALYSIS MARKET, BY MODALITY
7.1 INTRODUCTION
7.2 CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD)
7.2.1 SUPERIOR CLEARANCE OF HIGH-MOLECULAR-WEIGHT SUBSTANCES TO DRIVE MARKET
7.3 AUTOMATED PERITONEAL DIALYSIS (APD)
7.3.1 RISK OF RAPID DECLINE IN RESIDUAL RENAL FUNCTIONS TO LIMIT ADOPTION
8 PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION
8.1 INTRODUCTION
8.2 END-STAGE RENAL DISEASE
8.2.1 GROWING GERIATRIC POPULATION AND INCREASING PREVALENCE OF DIABETES TO DRIVE MARKET
8.3 ACUTE KIDNEY INJURY
8.3.1 INCREASING HOSPITALIZATIONS TO PROPEL MARKET GROWTH
8.4 OTHER DISEASES
9 PERITONEAL DIALYSIS MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOME CARE SETTINGS
9.2.1 LOWER COST AND SHORTER HOSPITAL STAYS TO AID MARKET GROWTH
9.3 HOSPITALS & INDEPENDENT DIALYSIS CENTERS
9.3.1 IMPROVED FACILITIES AND INCREASED GOVERNMENT SUPPORT TO DRIVE MARKET
9.4 OTHER END USERS
10 PERITONEAL DIALYSIS MARKET, BY REGION
10.1 INTRODUCTION
10.1.1 PERITONEAL DIALYSIS PREVALENCE DATA
10.1.2 PERITONEAL DIALYSIS PROCEDURE DATA
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 US to account for largest market share during study period
10.2.3 CANADA
10.2.3.1 Shortage of dialysis facilities and increased treatment cost
to limit market
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Rising number of end-stage renal disease (ESRD) patients to boost market growth
10.3.3 UK
10.3.3.1 Increased number of new dialysis centers and technological advancements to support market growth
10.3.4 FRANCE
10.3.4.1 Low cost of peritoneal dialysis and consistent reimbursement policies to drive market growth
10.3.5 ITALY
10.3.5.1 Increasing research activities and growing patient population with acute renal failure to augment market growth
10.3.6 SPAIN
10.3.6.1 Favorable reimbursement scenario to boost market growth
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 JAPAN
10.4.2.1 High prevalence of end-stage renal disease (ESRD) and large geriatric population to support market growth
10.4.3 CHINA
10.4.3.1 Increasing prevalence of diabetes and hypertension to drive market
10.4.4 INDIA
10.4.4.1 Favorable government initiatives and high prevalence of kidney disease to fuel market growth
10.4.5 AUSTRALIA
10.4.5.1 Increasing government initiatives about renal care to support market growth
10.4.6 SOUTH KOREA
10.4.6.1 Growing geriatric population with chronic kidney disease to propel market growth
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Brazil to account for largest share of Latin American market during forecast period
10.5.3 MEXICO
10.5.3.1 Increasing patient population and growing middle class population to boost market growth
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 GROWING DEMAND FOR CONVENIENT AND ACCESSIBLE RENAL CARE TO PROPEL GROWTH
10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.7 GCC COUNTRIES
10.7.1 HIGHER DISPOSABLE INCOME AND INCREASED GOVERNMENT HEALTHCARE EXPENDITURE TO PROPEL MARKET GROWTH
10.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PERITONEAL DIALYSIS MARKET
11.3 REVENUE ANALYSIS, 2019–2023
11.4 MARKET SHARE ANALYSIS, 2023
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.5.1 Company footprint
11.5.5.2 Offering footprint
11.5.5.3 Modality footprint
11.5.5.4 Disease indication footprint
11.5.5.5 End-user footprint
11.5.5.6 Region footprint
11.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
11.7 COMPANY VALUATION & FINANCIAL METRICS
11.8 COMPETITIVE SCENARIO
11.8.1 PRODUCT APPROVALS
11.8.2 DEALS
11.8.3 EXPANSIONS
11.9 BRAND/PRODUCT COMPARISON
11.10 PERITONEAL DIALYSIS MARKET: R&D EXPENDITURE
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 FRESENIUS MEDICAL CARE AG
12.1.1.1 Business overview
12.1.1.2 Products & services offered
12.1.1.3 Recent developments
12.1.1.3.1 Deals
12.1.1.4 MnM view
12.1.1.4.1 Right to win
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses & competitive threats
12.1.2 BAXTER INTERNATIONAL INC.
12.1.2.1 Business overview
12.1.2.2 Products & services offered
12.1.2.3 Recent developments
12.1.2.3.1 Deals
12.1.2.4 MnM view
12.1.2.4.1 Right to win
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses & competitive threats
12.1.3 MEDTRONIC PLC
12.1.3.1 Business overview
12.1.3.2 Products & services offered
12.1.3.3 Recent developments
12.1.3.3.1 Deals
12.1.3.4 MnM view
12.1.3.4.1 Right to win
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses & competitive threats
12.1.4 DAVITA INC.
12.1.4.1 Business overview
12.1.4.2 Products & services offered
12.1.4.3 Recent developments
12.1.4.3.1 Deals
12.1.4.3.2 Expansions
12.1.4.4 MnM view
12.1.4.4.1 Right to win
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses & competitive threats
12.1.5 BECTON, DICKINSON AND COMPANY
12.1.5.1 Business overview
12.1.5.2 Products & services offered
12.1.5.3 Recent developments
12.1.5.3.1 Expansions
12.1.5.4 MnM view
12.1.5.4.1 Right to win
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses & competitive threats
12.1.6 TERUMO CORPORATION
12.1.6.1 Business overview
12.1.6.2 Products & services offered
12.1.6.3 Recent developments
12.1.6.3.1 Product approvals
12.1.6.3.2 Deals
12.1.6.3.3 Expansions
12.1.7 UTAH MEDICAL PRODUCTS, INC.
12.1.7.1 Business overview
12.1.7.2 Products & services offered
12.1.8 DIAVERUM AB
12.1.8.1 Business overview
12.1.8.2 Products & services offered
12.1.9 MEDIONICS
12.1.9.1 Business overview
12.1.9.2 Products & services offered
12.1.10 NEWSOL TECHNOLOGIES INC.
12.1.10.1 Business overview
12.1.10.2 Products & services offered
12.1.11 APOLLO DIALYSIS PVT. LTD.
12.1.11.1 Business overview
12.1.11.2 Products & services offered
12.1.12 U.S. RENAL CARE, INC.
12.1.12.1 Business overview
12.1.12.2 Products & services offered
12.1.13 NORTHWEST KIDNEY CENTERS
12.1.13.1 Business overview
12.1.13.2 Products & services offered
12.1.13.3 Recent developments
12.1.13.3.1 Deals
12.1.13.3.2 Expansions
12.1.14 RELAVO
12.1.14.1 Business overview
12.1.14.2 Products & services offered
12.1.15 MITRA INDUSTRIES PVT. LTD.
12.1.15.1 Business overview
12.1.15.2 Products & services offered
12.2 OTHER PLAYERS
12.2.1 JMS CO., LTD.
12.2.2 AMECATH
12.2.3 POLYMEDICURE
12.2.4 HUAREN PHARMACEUTICAL
12.2.5 AWAK TECHNOLOGIES
12.2.6 INNOVATIVE RENAL CARE
12.2.7 ROMSONS
12.2.8 SSEM MTHEMBU MEDICAL (PTY) LTD.
12.2.9 RENAX BIOMEDICAL TECHNOLOGY CO., LTD.
12.2.10 ADVIN HEALTH CARE
13 APPENDIX
13.1 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.2 CUSTOMIZATION OPTIONS
13.3 RELATED REPORTS
13.4 AUTHOR DETAILS
TABLE 1 STANDARD CURRENCY CONVERSION RATES
TABLE 2 NUMBER OF PEOPLE AGED 65 YEARS OR OVER, BY REGION, 2022 VS. 2050
TABLE 3 UTILIZATION OF KIDNEY REPLACEMENT THERAPIES
(PERITONEAL DIALYSIS VS. HEMODIALYSIS)
TABLE 4 COST OF KIDNEY REPLACEMENT THERAPIES (2021)
TABLE 5 TRADE ANALYSIS OF MEDICAL DEVICE PRODUCTS
TABLE 6 IMPORT DATA FOR PERITONEAL DIALYSIS MACHINES, SOLUTION BAGS, CATHETERS, AND TRANSFER SETS (HS CODE 9018), BY COUNTRY,
2019–2023 (USD THOUSAND)
TABLE 7 EXPORT DATA FOR PERITONEAL DIALYSIS MACHINES, SOLUTION BAGS, CATHETERS AND TRANSFER SETS (HS CODE 9018), BY COUNTRY,
2019–2023 (USD THOUSAND)
TABLE 8 PERITONEAL DIALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 11 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 12 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 13 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 14 AVERAGE SELLING PRICE OF PERITONEAL DIALYSIS PRODUCTS AND CONSUMABLES, BY KEY PLAYER, 2023 (USD)
TABLE 15 PERITONEAL DIALYSIS MARKET: DETAILED LIST OF KEY CONFERENCES
& EVENTS, 2024–2025
TABLE 16 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR PERITONEAL DIALYSIS PRODUCTS
TABLE 17 BUYING CRITERIA FOR PERITONEAL DIALYSIS PRODUCTS
TABLE 18 PERITONEAL DIALYSIS MARKET: ECOSYSTEM ANALYSIS
TABLE 19 CASE STUDY 1: CUSTOMIZED DIALYSIS TUBING SETS
TABLE 20 CASE STUDY 2: CUSTOMIZED SOFTWARE FOR AUTOMATED PERITONEAL
DIALYSIS (APD) MACHINE
TABLE 21 PERITONEAL DIALYSIS MARKET: UNMET NEEDS
TABLE 22 PERITONEAL DIALYSIS MARKET: END-USER EXPECTATIONS
TABLE 23 PREVALENCE DATA, BY COUNTRY, 2021–2023 (PMP)
TABLE 24 NUMBER OF PERITONEAL DIALYSIS PATIENTS, BY REGION, 2019–2023
TABLE 25 NUMBER OF PERITONEAL DIALYSIS PATIENTS, BY REGION, 2024–2029
TABLE 26 PROCEDURE DATA FOR PERITONEAL DIALYSIS, BY COUNTRY, 2019–2023
TABLE 27 PROCEDURE DATA FOR PERITONEAL DIALYSIS, BY COUNTRY, 2024–2029
TABLE 28 PERITONEAL DIALYSIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 29 PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 30 PERITONEAL DIALYSIS PRODUCTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 31 AVERAGE VOLUME OF EXCHANGE, BY REGION, 2019–2023 (MILLION LITERS)
TABLE 32 AVERAGE VOLUME OF EXCHANGE, BY REGION, 2024–2029 (MILLION LITERS)
TABLE 33 PERITONEAL DIALYSIS SOLUTION BAGS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 34 PERITONEAL DIALYSIS SOLUTION BAGS MARKET,
BY REGION, 2022–2029 (THOUSAND UNITS)
TABLE 35 PERITONEAL DIALYSIS MACHINES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 36 PERITONEAL DIALYSIS MACHINES MARKET, BY REGION,
2022–2029 (THOUSAND UNITS)
TABLE 37 PERITONEAL DIALYSIS CATHETERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 38 PERITONEAL DIALYSIS TRANSFER SETS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 39 OTHER PERITONEAL DIALYSIS PRODUCTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 40 PERITONEAL DIALYSIS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 41 PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD MILLION)
TABLE 42 CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD) MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 43 AMBULATORY PERITONEAL DIALYSIS (APD) MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 44 PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION,
2022–2029 (USD MILLION)
TABLE 45 PERITONEAL DIALYSIS MARKET FOR END-STAGE RENAL DISEASE,
BY REGION, 2022–2029 (USD MILLION)
TABLE 46 PERITONEAL DIALYSIS MARKET FOR ACUTE KIDNEY INJURY,
BY REGION, 2022–2029 (USD MILLION)
TABLE 47 PERITONEAL DIALYSIS MARKET FOR OTHER DISEASES,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 48 PERITONEAL DIALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 49 PERITONEAL DIALYSIS MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 50 PERITONEAL DIALYSIS MARKET FOR HOSPITALS & INDEPENDENT DIALYSIS CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 51 PERITONEAL DIALYSIS MARKET FOR OTHER END USERS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 52 PERITONEAL DIALYSIS PREVALENCE DATA, BY COUNTRY, 2019–2023
TABLE 53 PERITONEAL DIALYSIS PREVALENCE DATA, BY COUNTRY, 2024–2029
TABLE 54 PERITONEAL DIALYSIS PROCEDURE DATA, BY REGION,
2019–2023 (MILLION PROCEDURES)
TABLE 55 PERITONEAL DIALYSIS PROCEDURE DATA, BY REGION,
2024–2029 (MILLION PROCEDURES)
TABLE 56 PERITONEAL DIALYSIS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 57 NORTH AMERICA: PERITONEAL DIALYSIS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 58 NORTH AMERICA: PERITONEAL DIALYSIS MARKET,
BY OFFERING, 2022–2029 (USD MILLION)
TABLE 59 NORTH AMERICA: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 60 NORTH AMERICA: PERITONEAL DIALYSIS MARKET,
BY MODALITY, 2022–2029 (USD MILLION)
TABLE 61 NORTH AMERICA: PERITONEAL DIALYSIS MARKET,
BY DISEASE INDICATION, 2022–2029 (USD MILLION)
TABLE 62 NORTH AMERICA: PERITONEAL DIALYSIS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 63 US: MACROECONOMIC INDICATORS
TABLE 64 US: PERITONEAL DIALYSIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 65 US: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 66 US: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD MILLION)
TABLE 67 US: PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION,
2022–2029 (USD MILLION)
TABLE 68 US: PERITONEAL DIALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 69 CANADA: MACROECONOMIC INDICATORS
TABLE 70 CANADA: PERITONEAL DIALYSIS MARKET, BY OFFERING,
2022–2029 (USD MILLION)
TABLE 71 CANADA: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 72 CANADA: PERITONEAL DIALYSIS MARKET, BY MODALITY,
2022–2029 (USD MILLION)
TABLE 73 CANADA: PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION,
2022–2029 (USD MILLION)
TABLE 74 CANADA: PERITONEAL DIALYSIS MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 75 EUROPE: PERITONEAL DIALYSIS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 76 EUROPE: PERITONEAL DIALYSIS MARKET, BY OFFERING,
2022–2029 (USD MILLION)
TABLE 77 EUROPE: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 78 EUROPE: PERITONEAL DIALYSIS MARKET, BY MODALITY,
2022–2029 (USD MILLION)
TABLE 79 EUROPE: PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION,
2022–2029 (USD MILLION)
TABLE 80 EUROPE: PERITONEAL DIALYSIS MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 81 GERMANY: MACROECONOMIC INDICATORS
TABLE 82 GERMANY: PERITONEAL DIALYSIS MARKET, BY OFFERING,
2022–2029 (USD MILLION)
TABLE 83 GERMANY: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 84 GERMANY: PERITONEAL DIALYSIS MARKET, BY MODALITY,
2022–2029 (USD MILLION)
TABLE 85 GERMANY: PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION,
2022–2029 (USD MILLION)
TABLE 86 GERMANY: PERITONEAL DIALYSIS MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 87 UK: MACROECONOMIC INDICATORS
TABLE 88 UK: PERITONEAL DIALYSIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 89 UK: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 90 UK: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD MILLION)
TABLE 91 UK: PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION,
2022–2029 (USD MILLION)
TABLE 92 UK: PERITONEAL DIALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 93 FRANCE: MACROECONOMIC INDICATORS
TABLE 94 FRANCE: PERITONEAL DIALYSIS MARKET, BY OFFERING,
2022–2029 (USD MILLION)
TABLE 95 FRANCE: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 96 FRANCE: PERITONEAL DIALYSIS MARKET, BY MODALITY,
2022–2029 (USD MILLION)
TABLE 97 FRANCE: PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION,
2022–2029 (USD MILLION)
TABLE 98 FRANCE: PERITONEAL DIALYSIS MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 99 ITALY: MACROECONOMIC INDICATORS
TABLE 100 ITALY: PERITONEAL DIALYSIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 101 ITALY: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 102 ITALY: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD MILLION)
TABLE 103 ITALY: PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION,
2022–2029 (USD MILLION)
TABLE 104 ITALY: PERITONEAL DIALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 105 SPAIN: MACROECONOMIC INDICATORS
TABLE 106 SPAIN: PERITONEAL DIALYSIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 107 SPAIN: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 108 SPAIN: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD MILLION)
TABLE 109 SPAIN: PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION,
2022–2029 (USD MILLION)
TABLE 110 SPAIN: PERITONEAL DIALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 111 REST OF EUROPE: PERITONEAL DIALYSIS MARKET, BY OFFERING,
2022–2029 (USD MILLION)
TABLE 112 REST OF EUROPE: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 113 REST OF EUROPE: PERITONEAL DIALYSIS MARKET,
BY MODALITY, 2022–2029 (USD MILLION)
TABLE 114 REST OF EUROPE: PERITONEAL DIALYSIS MARKET,
BY DISEASE INDICATION, 2022–2029 (USD MILLION)
TABLE 115 REST OF EUROPE: PERITONEAL DIALYSIS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 116 ASIA PACIFIC: PERITONEAL DIALYSIS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 117 ASIA PACIFIC: PERITONEAL DIALYSIS MARKET,
BY OFFERING, 2022–2029 (USD MILLION)
TABLE 118 ASIA PACIFIC: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 119 ASIA PACIFIC: PERITONEAL DIALYSIS MARKET,
BY MODALITY, 2022–2029 (USD MILLION)
TABLE 120 ASIA PACIFIC: PERITONEAL DIALYSIS MARKET,
BY DISEASE INDICATION, 2022–2029 (USD MILLION)
TABLE 121 ASIA PACIFIC: PERITONEAL DIALYSIS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 122 JAPAN: MACROECONOMIC INDICATORS
TABLE 123 JAPAN: PERITONEAL DIALYSIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 124 JAPAN: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 125 JAPAN: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD MILLION)
TABLE 126 JAPAN: PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION,
2022–2029 (USD MILLION)
TABLE 127 JAPAN: PERITONEAL DIALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 128 CHINA: MACROECONOMIC INDICATORS
TABLE 129 CHINA: PERITONEAL DIALYSIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 130 CHINA: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 131 CHINA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD MILLION)
TABLE 132 CHINA: PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION,
2022–2029 (USD MILLION)
TABLE 133 CHINA: PERITONEAL DIALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 134 INDIA: MACROECONOMIC INDICATORS
TABLE 135 INDIA: PERITONEAL DIALYSIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 136 INDIA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 137 INDIA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD MILLION)
TABLE 138 INDIA: PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION,
2022–2029 (USD MILLION)
TABLE 139 INDIA: PERITONEAL DIALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 140 AUSTRALIA: MACROECONOMIC INDICATORS
TABLE 141 AUSTRALIA: PERITONEAL DIALYSIS MARKET, BY OFFERING,
2022–2029 (USD MILLION)
TABLE 142 AUSTRALIA: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 143 AUSTRALIA: PERITONEAL DIALYSIS MARKET, BY MODALITY,
2022–2029 (USD MILLION)
TABLE 144 AUSTRALIA: PERITONEAL DIALYSIS MARKET,
BY DISEASE INDICATION, 2022–2029 (USD MILLION)
TABLE 145 AUSTRALIA: PERITONEAL DIALYSIS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 146 SOUTH KOREA: MACROECONOMIC INDICATORS
TABLE 147 SOUTH KOREA: PERITONEAL DIALYSIS MARKET,
BY OFFERING, 2022–2029 (USD MILLION)
TABLE 148 SOUTH KOREA: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 149 SOUTH KOREA: PERITONEAL DIALYSIS MARKET,
BY MODALITY, 2022–2029 (USD MILLION)
TABLE 150 SOUTH KOREA: PERITONEAL DIALYSIS MARKET,
BY DISEASE INDICATION, 2022–2029 (USD MILLION)
TABLE 151 SOUTH KOREA: PERITONEAL DIALYSIS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 152 REST OF ASIA PACIFIC: PERITONEAL DIALYSIS MARKET,
BY OFFERING, 2022–2029 (USD MILLION)
TABLE 153 REST OF ASIA PACIFIC: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 154 REST OF ASIA PACIFIC: PERITONEAL DIALYSIS MARKET,
BY MODALITY, 2022–2029 (USD MILLION)
TABLE 155 REST OF ASIA PACIFIC: PERITONEAL DIALYSIS MARKET,
BY DISEASE INDICATION, 2022–2029 (USD MILLION)
TABLE 156 REST OF ASIA PACIFIC: PERITONEAL DIALYSIS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 157 LATIN AMERICA: PERITONEAL DIALYSIS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 158 LATIN AMERICA: PERITONEAL DIALYSIS MARKET,
BY OFFERING, 2022–2029 (USD MILLION)
TABLE 159 LATIN AMERICA: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 160 LATIN AMERICA: PERITONEAL DIALYSIS MARKET,
BY MODALITY, 2022–2029 (USD MILLION)
TABLE 161 LATIN AMERICA: PERITONEAL DIALYSIS MARKET,
BY DISEASE INDICATION, 2022–2029 (USD MILLION)
TABLE 162 LATIN AMERICA: PERITONEAL DIALYSIS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 163 BRAZIL: MACROECONOMIC INDICATORS
TABLE 164 BRAZIL: PERITONEAL DIALYSIS MARKET, BY OFFERING,
2022–2029 (USD MILLION)
TABLE 165 BRAZIL: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 166 BRAZIL: PERITONEAL DIALYSIS MARKET, BY MODALITY,
2022–2029 (USD MILLION)
TABLE 167 BRAZIL: PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION,
2022–2029 (USD MILLION)
TABLE 168 BRAZIL: PERITONEAL DIALYSIS MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 169 MEXICO: MACROECONOMIC INDICATORS
TABLE 170 MEXICO: PERITONEAL DIALYSIS MARKET, BY OFFERING,
2022–2029 (USD MILLION)
TABLE 171 MEXICO: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 172 MEXICO: PERITONEAL DIALYSIS MARKET,
BY MODALITY, 2022–2029 (USD MILLION)
TABLE 173 MEXICO: PERITONEAL DIALYSIS MARKET,
BY DISEASE INDICATION, 2022–2029 (USD MILLION)
TABLE 174 MEXICO: PERITONEAL DIALYSIS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 175 REST OF LATIN AMERICA: PERITONEAL DIALYSIS MARKET,
BY OFFERING, 2022–2029 (USD MILLION)
TABLE 176 REST OF LATIN AMERICA: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 177 REST OF LATIN AMERICA: PERITONEAL DIALYSIS MARKET,
BY MODALITY, 2022–2029 (USD MILLION)
TABLE 178 REST OF LATIN AMERICA: PERITONEAL DIALYSIS MARKET,
BY DISEASE INDICATION, 2022–2029 (USD MILLION)
TABLE 179 REST OF LATIN AMERICA: PERITONEAL DIALYSIS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 180 MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS MARKET,
BY OFFERING, 2022–2029 (USD MILLION)
TABLE 181 MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 182 MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS MARKET,
BY MODALITY, 2022–2029 (USD MILLION)
TABLE 183 MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS MARKET,
BY DISEASE INDICATION, 2022–2029 (USD MILLION)
TABLE 184 MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 185 GCC COUNTRIES: PERITONEAL DIALYSIS MARKET,
BY OFFERING, 2022–2029 (USD MILLION)
TABLE 186 GCC COUNTRIES: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 187 GCC COUNTRIES: PERITONEAL DIALYSIS MARKET,
BY MODALITY, 2022–2029 (USD MILLION)
TABLE 188 GCC COUNTRIES: PERITONEAL DIALYSIS MARKET,
BY DISEASE INDICATION, 2022–2029 (USD MILLION)
TABLE 189 GCC COUNTRIES: PERITONEAL DIALYSIS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 190 PERITONEAL DIALYSIS MARKET: DEGREE OF COMPETITION
TABLE 191 PERITONEAL DIALYSIS MARKET: OFFERING FOOTPRINT
TABLE 192 PERITONEAL DIALYSIS MARKET: MODALITY FOOTPRINT
TABLE 193 PERITONEAL DIALYSIS MARKET: DISEASE INDICATION FOOTPRINT
TABLE 194 PERITONEAL DIALYSIS MARKET: END-USER FOOTPRINT
TABLE 195 PERITONEAL DIALYSIS MARKET: REGION FOOTPRINT
TABLE 196 PERITONEAL DIALYSIS MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS
TABLE 197 PERITONEAL DIALYSIS MARKET: COMPETITIVE BENCHMARKING OF
KEY START-UP/SME PLAYERS REGION FOOTPRINT
TABLE 198 PERITONEAL DIALYSIS MARKET: PRODUCT APPROVALS
(JANUARY 2021- SEPTEMBER 2024)
TABLE 199 PERITONEAL DIALYSIS MARKET: DEALS, JANUARY 2020–SEPTEMBER 2024
TABLE 200 PERITONEAL DIALYSIS MARKET: EXPANSIONS, JANUARY 2020–SEPTEMBER 2024
TABLE 201 FRESENIUS MEDICAL CARE AG: COMPANY OVERVIEW
TABLE 202 FRESENIUS MEDICAL CARE AG: PRODUCTS & SERVICES OFFERED
TABLE 203 FRESENIUS MEDICAL CARE AG: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 204 BAXTER INTERNATIONAL INC.: COMPANY OVERVIEW
TABLE 205 BAXTER INTERNATIONAL INC.: PRODUCTS & SERVICES OFFERED
TABLE 206 BAXTER INTERNATIONAL INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 207 MEDTRONIC PLC: COMPANY OVERVIEW
TABLE 208 MEDTRONIC PLC: PRODUCTS & SERVICES OFFERED
TABLE 209 MEDTRONIC PLC: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 210 DAVITA INC.: COMPANY OVERVIEW
TABLE 211 DAVITA INC.: PRODUCTS & SERVICES OFFERED
TABLE 212 DAVITA INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 213 DAVITA INC.: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
TABLE 214 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
TABLE 215 BECTON, DICKINSON AND COMPANY: PRODUCTS & SERVICES OFFERED
TABLE 216 BECTON, DICKINSON AND COMPANY: EXPANSIONS,
JANUARY 2021–SEPTEMBER 2024
TABLE 217 TERUMO CORPORATION: COMPANY OVERVIEW
TABLE 218 TERUMO CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 219 TERUMO CORPORATION: PRODUCT APPROVALS,
JANUARY 2021–SEPTEMBER 2024
TABLE 220 TERUMO CORPORATION: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 221 TERUMO CORPORATION: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
TABLE 222 UTAH MEDICAL PRODUCTS, INC.: BUSINESS OVERVIEW
TABLE 223 UTAH MEDICAL PRODUCTS, INC.: PRODUCTS & SERVICES OFFERED
TABLE 224 DIAVERUM AB: COMPANY OVERVIEW
TABLE 225 DIAVERUM AB: PRODUCTS & SERVICES OFFERED
TABLE 226 MEDIONICS: BUSINESS OVERVIEW
TABLE 227 MEDIONICS: PRODUCTS & SERVICES OFFERED
TABLE 228 NEWSOL TECHNOLOGIES INC.: COMPANY OVERVIEW
TABLE 229 NEWSOL TECHNOLOGIES INC.: PRODUCTS & SERVICES OFFERED
TABLE 230 APOLLO DIALYSIS PVT. LTD.: BUSINESS OVERVIEW
TABLE 231 APOLLO DIALYSIS PVT. LTD.: PRODUCTS & SERVICES OFFERED
TABLE 232 U.S. RENAL CARE, INC.: BUSINESS OVERVIEW
TABLE 233 U.S. RENAL CARE, INC.: PRODUCTS & SERVICES OFFERED
TABLE 234 NORTHWEST KIDNEY CENTERS: COMPANY OVERVIEW
TABLE 235 NORTHWEST KIDNEY CENTERS: PRODUCTS & SERVICES OFFERED
TABLE 236 NORTHWEST KIDNEY CENTERS: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 237 NORTHWEST KIDNEY CENTERS: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
TABLE 238 RELAVO: COMPANY OVERVIEW
TABLE 239 RELAVO: PRODUCTS & SERVICES OFFERED
TABLE 240 MITRA INDUSTRIES PVT. LTD.: BUSINESS OVERVIEW
TABLE 241 MITRA INDUSTRIES PVT. LTD.: PRODUCTS & SERVICES OFFERED
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 IMPACT OF AI/GEN AI
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.2 MARKET SIZE ESTIMATION
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
2.2.3 USAGE-BASED MARKET ESTIMATION
2.2.4 PRIMARY RESEARCH VALIDATION
2.3 GROWTH FORECAST ESTIMATION
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PERITONEAL DIALYSIS MARKET OVERVIEW
4.2 ASIA PACIFIC: PERITONEAL DIALYSIS MARKET, BY OFFERING (2023)
4.3 PERITONEAL DIALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 REGIONAL MIX: PERITONEAL DIALYSIS MARKET (2024?2029)
4.5 PERITONEAL DIALYSIS MARKET: DEVELOPED VS. DEVELOPING ECONOMIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of chronic kidney diseases
5.2.1.2 Growing prevalence of diabetes and hypertension
5.2.1.3 Technological advancements and increased investment in R&D
5.2.2 RESTRAINTS
5.2.2.1 Underutilization of peritoneal dialysis in low-income and lower-middle-income countries (LLMICs)
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing growth opportunities in emerging economies
5.2.3.2 Surge in demand for home dialysis treatment
5.2.4 CHALLENGES
5.2.4.1 Shortage of skilled nephrologists in low-income and lower-middle-income countries (LLMICs)
5.2.4.2 High risk of peritonitis as a barrier to peritoneal dialysis adoption
5.3 INDUSTRY TRENDS
5.3.1 INCREASED ADOPTION OF HOME-BASED TREATMENTS
5.3.2 RISING INCIDENCE OF CHRONIC KIDNEY DISEASE (CKD)
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 Automated peritoneal dialysis (APD) machines
5.4.2 COMPLEMENTARY TECHNOLOGIES
5.4.2.1 Remote monitoring systems
5.4.3 ADJACENT TECHNOLOGIES
5.4.3.1 Wearable technology
5.5 SUPPLY CHAIN ANALYSIS
5.6 VALUE CHAIN ANALYSIS
5.7 TRADE ANALYSIS
5.7.1 TRADE ANALYSIS FOR PERITONEAL DIALYSIS MACHINES, SOLUTION BAGS, CATHETERS, AND TRANSFER SETS (HS CODE 9018)
5.8 PORTER’S FIVE FORCES ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF SUPPLIERS
5.8.4 BARGAINING POWER OF BUYERS
5.8.5 INTENSITY OF COMPETITIVE RIVALRY
5.9 REGULATORY ANALYSIS
5.9.1 REGULATORY LANDSCAPE
5.9.1.1 North America
5.9.1.1.1 US
5.9.1.1.2 Canada
5.9.1.2 Europe
5.9.1.3 Asia Pacific
5.9.1.3.1 India
5.9.1.3.2 China
5.9.1.3.3 Japan
5.9.1.3.4 South Korea
5.9.1.4 Latin America
5.9.1.4.1 Brazil
5.9.1.4.2 Mexico
5.9.1.5 Middle East
5.9.1.6 Africa
5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.10 PATENT ANALYSIS
5.10.1 PATENT PUBLICATION TRENDS FOR PERITONEAL DIALYSIS MARKET
5.10.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.11 PRICING ANALYSIS
5.11.1 AVERAGE SELLING PRICE OF PERITONEAL DIALYSIS PRODUCTS AND CONSUMABLES, BY KEY PLAYER (2023)
5.12 KEY CONFERENCES & EVENTS, 2024–2025
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2 KEY BUYING CRITERIA
5.14 ECOSYSTEM ANALYSIS
5.15 ADJACENT MARKET ANALYSIS
5.15.1 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
5.15.2 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET
5.16 CASE STUDY ANALYSIS
5.17 IMPACT OF GENERATIVE AI ON PERITONEAL DIALYSIS MARKET
5.18 UNMET NEEDS AND END-USER EXPECTATIONS
5.19 TRENDS/DISRUPTIONS AFFECTING CUSTOMERS’ BUSINESSES
5.20 INVESTMENT & FUNDING SCENARIO
5.21 PROCEDURE DATA ANALYSIS
5.21.1 PREVALENCE DATA FOR TREATED KIDNEY FAILURE
6 PERITONEAL DIALYSIS MARKET, BY OFFERING
6.1 INTRODUCTION
6.2 PERITONEAL DIALYSIS PRODUCTS
6.2.1 PERITONEAL DIALYSIS SOLUTION BAGS
6.2.1.1 High demand for solutions to boost segmental growth
6.2.2 PERITONEAL DIALYSIS MACHINES
6.2.2.1 Rising prevalence of chronic diseases in emerging economies to boost adoption
6.2.3 PERITONEAL DIALYSIS CATHETERS
6.2.3.1 Favorable reimbursement policies to support market growth
6.2.4 PERITONEAL DIALYSIS TRANSFER SETS
6.2.4.1 Product recalls to limit market growth
6.2.5 OTHER PERITONEAL DIALYSIS PRODUCTS
6.3 PERITONEAL DIALYSIS SERVICES
6.3.1 BETTER PRIVACY AND INCREASED COMFORT OF AT-HOME DIALYSIS TREATMENT TO DRIVE MARKET
7 PERITONEAL DIALYSIS MARKET, BY MODALITY
7.1 INTRODUCTION
7.2 CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD)
7.2.1 SUPERIOR CLEARANCE OF HIGH-MOLECULAR-WEIGHT SUBSTANCES TO DRIVE MARKET
7.3 AUTOMATED PERITONEAL DIALYSIS (APD)
7.3.1 RISK OF RAPID DECLINE IN RESIDUAL RENAL FUNCTIONS TO LIMIT ADOPTION
8 PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION
8.1 INTRODUCTION
8.2 END-STAGE RENAL DISEASE
8.2.1 GROWING GERIATRIC POPULATION AND INCREASING PREVALENCE OF DIABETES TO DRIVE MARKET
8.3 ACUTE KIDNEY INJURY
8.3.1 INCREASING HOSPITALIZATIONS TO PROPEL MARKET GROWTH
8.4 OTHER DISEASES
9 PERITONEAL DIALYSIS MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOME CARE SETTINGS
9.2.1 LOWER COST AND SHORTER HOSPITAL STAYS TO AID MARKET GROWTH
9.3 HOSPITALS & INDEPENDENT DIALYSIS CENTERS
9.3.1 IMPROVED FACILITIES AND INCREASED GOVERNMENT SUPPORT TO DRIVE MARKET
9.4 OTHER END USERS
10 PERITONEAL DIALYSIS MARKET, BY REGION
10.1 INTRODUCTION
10.1.1 PERITONEAL DIALYSIS PREVALENCE DATA
10.1.2 PERITONEAL DIALYSIS PROCEDURE DATA
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 US to account for largest market share during study period
10.2.3 CANADA
10.2.3.1 Shortage of dialysis facilities and increased treatment cost
to limit market
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Rising number of end-stage renal disease (ESRD) patients to boost market growth
10.3.3 UK
10.3.3.1 Increased number of new dialysis centers and technological advancements to support market growth
10.3.4 FRANCE
10.3.4.1 Low cost of peritoneal dialysis and consistent reimbursement policies to drive market growth
10.3.5 ITALY
10.3.5.1 Increasing research activities and growing patient population with acute renal failure to augment market growth
10.3.6 SPAIN
10.3.6.1 Favorable reimbursement scenario to boost market growth
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 JAPAN
10.4.2.1 High prevalence of end-stage renal disease (ESRD) and large geriatric population to support market growth
10.4.3 CHINA
10.4.3.1 Increasing prevalence of diabetes and hypertension to drive market
10.4.4 INDIA
10.4.4.1 Favorable government initiatives and high prevalence of kidney disease to fuel market growth
10.4.5 AUSTRALIA
10.4.5.1 Increasing government initiatives about renal care to support market growth
10.4.6 SOUTH KOREA
10.4.6.1 Growing geriatric population with chronic kidney disease to propel market growth
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Brazil to account for largest share of Latin American market during forecast period
10.5.3 MEXICO
10.5.3.1 Increasing patient population and growing middle class population to boost market growth
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 GROWING DEMAND FOR CONVENIENT AND ACCESSIBLE RENAL CARE TO PROPEL GROWTH
10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.7 GCC COUNTRIES
10.7.1 HIGHER DISPOSABLE INCOME AND INCREASED GOVERNMENT HEALTHCARE EXPENDITURE TO PROPEL MARKET GROWTH
10.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PERITONEAL DIALYSIS MARKET
11.3 REVENUE ANALYSIS, 2019–2023
11.4 MARKET SHARE ANALYSIS, 2023
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.5.1 Company footprint
11.5.5.2 Offering footprint
11.5.5.3 Modality footprint
11.5.5.4 Disease indication footprint
11.5.5.5 End-user footprint
11.5.5.6 Region footprint
11.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
11.7 COMPANY VALUATION & FINANCIAL METRICS
11.8 COMPETITIVE SCENARIO
11.8.1 PRODUCT APPROVALS
11.8.2 DEALS
11.8.3 EXPANSIONS
11.9 BRAND/PRODUCT COMPARISON
11.10 PERITONEAL DIALYSIS MARKET: R&D EXPENDITURE
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 FRESENIUS MEDICAL CARE AG
12.1.1.1 Business overview
12.1.1.2 Products & services offered
12.1.1.3 Recent developments
12.1.1.3.1 Deals
12.1.1.4 MnM view
12.1.1.4.1 Right to win
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses & competitive threats
12.1.2 BAXTER INTERNATIONAL INC.
12.1.2.1 Business overview
12.1.2.2 Products & services offered
12.1.2.3 Recent developments
12.1.2.3.1 Deals
12.1.2.4 MnM view
12.1.2.4.1 Right to win
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses & competitive threats
12.1.3 MEDTRONIC PLC
12.1.3.1 Business overview
12.1.3.2 Products & services offered
12.1.3.3 Recent developments
12.1.3.3.1 Deals
12.1.3.4 MnM view
12.1.3.4.1 Right to win
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses & competitive threats
12.1.4 DAVITA INC.
12.1.4.1 Business overview
12.1.4.2 Products & services offered
12.1.4.3 Recent developments
12.1.4.3.1 Deals
12.1.4.3.2 Expansions
12.1.4.4 MnM view
12.1.4.4.1 Right to win
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses & competitive threats
12.1.5 BECTON, DICKINSON AND COMPANY
12.1.5.1 Business overview
12.1.5.2 Products & services offered
12.1.5.3 Recent developments
12.1.5.3.1 Expansions
12.1.5.4 MnM view
12.1.5.4.1 Right to win
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses & competitive threats
12.1.6 TERUMO CORPORATION
12.1.6.1 Business overview
12.1.6.2 Products & services offered
12.1.6.3 Recent developments
12.1.6.3.1 Product approvals
12.1.6.3.2 Deals
12.1.6.3.3 Expansions
12.1.7 UTAH MEDICAL PRODUCTS, INC.
12.1.7.1 Business overview
12.1.7.2 Products & services offered
12.1.8 DIAVERUM AB
12.1.8.1 Business overview
12.1.8.2 Products & services offered
12.1.9 MEDIONICS
12.1.9.1 Business overview
12.1.9.2 Products & services offered
12.1.10 NEWSOL TECHNOLOGIES INC.
12.1.10.1 Business overview
12.1.10.2 Products & services offered
12.1.11 APOLLO DIALYSIS PVT. LTD.
12.1.11.1 Business overview
12.1.11.2 Products & services offered
12.1.12 U.S. RENAL CARE, INC.
12.1.12.1 Business overview
12.1.12.2 Products & services offered
12.1.13 NORTHWEST KIDNEY CENTERS
12.1.13.1 Business overview
12.1.13.2 Products & services offered
12.1.13.3 Recent developments
12.1.13.3.1 Deals
12.1.13.3.2 Expansions
12.1.14 RELAVO
12.1.14.1 Business overview
12.1.14.2 Products & services offered
12.1.15 MITRA INDUSTRIES PVT. LTD.
12.1.15.1 Business overview
12.1.15.2 Products & services offered
12.2 OTHER PLAYERS
12.2.1 JMS CO., LTD.
12.2.2 AMECATH
12.2.3 POLYMEDICURE
12.2.4 HUAREN PHARMACEUTICAL
12.2.5 AWAK TECHNOLOGIES
12.2.6 INNOVATIVE RENAL CARE
12.2.7 ROMSONS
12.2.8 SSEM MTHEMBU MEDICAL (PTY) LTD.
12.2.9 RENAX BIOMEDICAL TECHNOLOGY CO., LTD.
12.2.10 ADVIN HEALTH CARE
13 APPENDIX
13.1 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.2 CUSTOMIZATION OPTIONS
13.3 RELATED REPORTS
13.4 AUTHOR DETAILS
TABLE 1 STANDARD CURRENCY CONVERSION RATES
TABLE 2 NUMBER OF PEOPLE AGED 65 YEARS OR OVER, BY REGION, 2022 VS. 2050
TABLE 3 UTILIZATION OF KIDNEY REPLACEMENT THERAPIES
(PERITONEAL DIALYSIS VS. HEMODIALYSIS)
TABLE 4 COST OF KIDNEY REPLACEMENT THERAPIES (2021)
TABLE 5 TRADE ANALYSIS OF MEDICAL DEVICE PRODUCTS
TABLE 6 IMPORT DATA FOR PERITONEAL DIALYSIS MACHINES, SOLUTION BAGS, CATHETERS, AND TRANSFER SETS (HS CODE 9018), BY COUNTRY,
2019–2023 (USD THOUSAND)
TABLE 7 EXPORT DATA FOR PERITONEAL DIALYSIS MACHINES, SOLUTION BAGS, CATHETERS AND TRANSFER SETS (HS CODE 9018), BY COUNTRY,
2019–2023 (USD THOUSAND)
TABLE 8 PERITONEAL DIALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 11 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 12 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 13 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 14 AVERAGE SELLING PRICE OF PERITONEAL DIALYSIS PRODUCTS AND CONSUMABLES, BY KEY PLAYER, 2023 (USD)
TABLE 15 PERITONEAL DIALYSIS MARKET: DETAILED LIST OF KEY CONFERENCES
& EVENTS, 2024–2025
TABLE 16 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR PERITONEAL DIALYSIS PRODUCTS
TABLE 17 BUYING CRITERIA FOR PERITONEAL DIALYSIS PRODUCTS
TABLE 18 PERITONEAL DIALYSIS MARKET: ECOSYSTEM ANALYSIS
TABLE 19 CASE STUDY 1: CUSTOMIZED DIALYSIS TUBING SETS
TABLE 20 CASE STUDY 2: CUSTOMIZED SOFTWARE FOR AUTOMATED PERITONEAL
DIALYSIS (APD) MACHINE
TABLE 21 PERITONEAL DIALYSIS MARKET: UNMET NEEDS
TABLE 22 PERITONEAL DIALYSIS MARKET: END-USER EXPECTATIONS
TABLE 23 PREVALENCE DATA, BY COUNTRY, 2021–2023 (PMP)
TABLE 24 NUMBER OF PERITONEAL DIALYSIS PATIENTS, BY REGION, 2019–2023
TABLE 25 NUMBER OF PERITONEAL DIALYSIS PATIENTS, BY REGION, 2024–2029
TABLE 26 PROCEDURE DATA FOR PERITONEAL DIALYSIS, BY COUNTRY, 2019–2023
TABLE 27 PROCEDURE DATA FOR PERITONEAL DIALYSIS, BY COUNTRY, 2024–2029
TABLE 28 PERITONEAL DIALYSIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 29 PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 30 PERITONEAL DIALYSIS PRODUCTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 31 AVERAGE VOLUME OF EXCHANGE, BY REGION, 2019–2023 (MILLION LITERS)
TABLE 32 AVERAGE VOLUME OF EXCHANGE, BY REGION, 2024–2029 (MILLION LITERS)
TABLE 33 PERITONEAL DIALYSIS SOLUTION BAGS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 34 PERITONEAL DIALYSIS SOLUTION BAGS MARKET,
BY REGION, 2022–2029 (THOUSAND UNITS)
TABLE 35 PERITONEAL DIALYSIS MACHINES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 36 PERITONEAL DIALYSIS MACHINES MARKET, BY REGION,
2022–2029 (THOUSAND UNITS)
TABLE 37 PERITONEAL DIALYSIS CATHETERS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 38 PERITONEAL DIALYSIS TRANSFER SETS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 39 OTHER PERITONEAL DIALYSIS PRODUCTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 40 PERITONEAL DIALYSIS SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 41 PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD MILLION)
TABLE 42 CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD) MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 43 AMBULATORY PERITONEAL DIALYSIS (APD) MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 44 PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION,
2022–2029 (USD MILLION)
TABLE 45 PERITONEAL DIALYSIS MARKET FOR END-STAGE RENAL DISEASE,
BY REGION, 2022–2029 (USD MILLION)
TABLE 46 PERITONEAL DIALYSIS MARKET FOR ACUTE KIDNEY INJURY,
BY REGION, 2022–2029 (USD MILLION)
TABLE 47 PERITONEAL DIALYSIS MARKET FOR OTHER DISEASES,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 48 PERITONEAL DIALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 49 PERITONEAL DIALYSIS MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 50 PERITONEAL DIALYSIS MARKET FOR HOSPITALS & INDEPENDENT DIALYSIS CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 51 PERITONEAL DIALYSIS MARKET FOR OTHER END USERS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 52 PERITONEAL DIALYSIS PREVALENCE DATA, BY COUNTRY, 2019–2023
TABLE 53 PERITONEAL DIALYSIS PREVALENCE DATA, BY COUNTRY, 2024–2029
TABLE 54 PERITONEAL DIALYSIS PROCEDURE DATA, BY REGION,
2019–2023 (MILLION PROCEDURES)
TABLE 55 PERITONEAL DIALYSIS PROCEDURE DATA, BY REGION,
2024–2029 (MILLION PROCEDURES)
TABLE 56 PERITONEAL DIALYSIS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 57 NORTH AMERICA: PERITONEAL DIALYSIS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 58 NORTH AMERICA: PERITONEAL DIALYSIS MARKET,
BY OFFERING, 2022–2029 (USD MILLION)
TABLE 59 NORTH AMERICA: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 60 NORTH AMERICA: PERITONEAL DIALYSIS MARKET,
BY MODALITY, 2022–2029 (USD MILLION)
TABLE 61 NORTH AMERICA: PERITONEAL DIALYSIS MARKET,
BY DISEASE INDICATION, 2022–2029 (USD MILLION)
TABLE 62 NORTH AMERICA: PERITONEAL DIALYSIS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 63 US: MACROECONOMIC INDICATORS
TABLE 64 US: PERITONEAL DIALYSIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 65 US: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 66 US: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD MILLION)
TABLE 67 US: PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION,
2022–2029 (USD MILLION)
TABLE 68 US: PERITONEAL DIALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 69 CANADA: MACROECONOMIC INDICATORS
TABLE 70 CANADA: PERITONEAL DIALYSIS MARKET, BY OFFERING,
2022–2029 (USD MILLION)
TABLE 71 CANADA: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 72 CANADA: PERITONEAL DIALYSIS MARKET, BY MODALITY,
2022–2029 (USD MILLION)
TABLE 73 CANADA: PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION,
2022–2029 (USD MILLION)
TABLE 74 CANADA: PERITONEAL DIALYSIS MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 75 EUROPE: PERITONEAL DIALYSIS MARKET, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 76 EUROPE: PERITONEAL DIALYSIS MARKET, BY OFFERING,
2022–2029 (USD MILLION)
TABLE 77 EUROPE: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 78 EUROPE: PERITONEAL DIALYSIS MARKET, BY MODALITY,
2022–2029 (USD MILLION)
TABLE 79 EUROPE: PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION,
2022–2029 (USD MILLION)
TABLE 80 EUROPE: PERITONEAL DIALYSIS MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 81 GERMANY: MACROECONOMIC INDICATORS
TABLE 82 GERMANY: PERITONEAL DIALYSIS MARKET, BY OFFERING,
2022–2029 (USD MILLION)
TABLE 83 GERMANY: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 84 GERMANY: PERITONEAL DIALYSIS MARKET, BY MODALITY,
2022–2029 (USD MILLION)
TABLE 85 GERMANY: PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION,
2022–2029 (USD MILLION)
TABLE 86 GERMANY: PERITONEAL DIALYSIS MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 87 UK: MACROECONOMIC INDICATORS
TABLE 88 UK: PERITONEAL DIALYSIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 89 UK: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 90 UK: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD MILLION)
TABLE 91 UK: PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION,
2022–2029 (USD MILLION)
TABLE 92 UK: PERITONEAL DIALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 93 FRANCE: MACROECONOMIC INDICATORS
TABLE 94 FRANCE: PERITONEAL DIALYSIS MARKET, BY OFFERING,
2022–2029 (USD MILLION)
TABLE 95 FRANCE: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 96 FRANCE: PERITONEAL DIALYSIS MARKET, BY MODALITY,
2022–2029 (USD MILLION)
TABLE 97 FRANCE: PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION,
2022–2029 (USD MILLION)
TABLE 98 FRANCE: PERITONEAL DIALYSIS MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 99 ITALY: MACROECONOMIC INDICATORS
TABLE 100 ITALY: PERITONEAL DIALYSIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 101 ITALY: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 102 ITALY: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD MILLION)
TABLE 103 ITALY: PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION,
2022–2029 (USD MILLION)
TABLE 104 ITALY: PERITONEAL DIALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 105 SPAIN: MACROECONOMIC INDICATORS
TABLE 106 SPAIN: PERITONEAL DIALYSIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 107 SPAIN: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 108 SPAIN: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD MILLION)
TABLE 109 SPAIN: PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION,
2022–2029 (USD MILLION)
TABLE 110 SPAIN: PERITONEAL DIALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 111 REST OF EUROPE: PERITONEAL DIALYSIS MARKET, BY OFFERING,
2022–2029 (USD MILLION)
TABLE 112 REST OF EUROPE: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 113 REST OF EUROPE: PERITONEAL DIALYSIS MARKET,
BY MODALITY, 2022–2029 (USD MILLION)
TABLE 114 REST OF EUROPE: PERITONEAL DIALYSIS MARKET,
BY DISEASE INDICATION, 2022–2029 (USD MILLION)
TABLE 115 REST OF EUROPE: PERITONEAL DIALYSIS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 116 ASIA PACIFIC: PERITONEAL DIALYSIS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 117 ASIA PACIFIC: PERITONEAL DIALYSIS MARKET,
BY OFFERING, 2022–2029 (USD MILLION)
TABLE 118 ASIA PACIFIC: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 119 ASIA PACIFIC: PERITONEAL DIALYSIS MARKET,
BY MODALITY, 2022–2029 (USD MILLION)
TABLE 120 ASIA PACIFIC: PERITONEAL DIALYSIS MARKET,
BY DISEASE INDICATION, 2022–2029 (USD MILLION)
TABLE 121 ASIA PACIFIC: PERITONEAL DIALYSIS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 122 JAPAN: MACROECONOMIC INDICATORS
TABLE 123 JAPAN: PERITONEAL DIALYSIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 124 JAPAN: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 125 JAPAN: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD MILLION)
TABLE 126 JAPAN: PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION,
2022–2029 (USD MILLION)
TABLE 127 JAPAN: PERITONEAL DIALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 128 CHINA: MACROECONOMIC INDICATORS
TABLE 129 CHINA: PERITONEAL DIALYSIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 130 CHINA: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 131 CHINA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD MILLION)
TABLE 132 CHINA: PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION,
2022–2029 (USD MILLION)
TABLE 133 CHINA: PERITONEAL DIALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 134 INDIA: MACROECONOMIC INDICATORS
TABLE 135 INDIA: PERITONEAL DIALYSIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 136 INDIA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 137 INDIA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD MILLION)
TABLE 138 INDIA: PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION,
2022–2029 (USD MILLION)
TABLE 139 INDIA: PERITONEAL DIALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 140 AUSTRALIA: MACROECONOMIC INDICATORS
TABLE 141 AUSTRALIA: PERITONEAL DIALYSIS MARKET, BY OFFERING,
2022–2029 (USD MILLION)
TABLE 142 AUSTRALIA: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 143 AUSTRALIA: PERITONEAL DIALYSIS MARKET, BY MODALITY,
2022–2029 (USD MILLION)
TABLE 144 AUSTRALIA: PERITONEAL DIALYSIS MARKET,
BY DISEASE INDICATION, 2022–2029 (USD MILLION)
TABLE 145 AUSTRALIA: PERITONEAL DIALYSIS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 146 SOUTH KOREA: MACROECONOMIC INDICATORS
TABLE 147 SOUTH KOREA: PERITONEAL DIALYSIS MARKET,
BY OFFERING, 2022–2029 (USD MILLION)
TABLE 148 SOUTH KOREA: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 149 SOUTH KOREA: PERITONEAL DIALYSIS MARKET,
BY MODALITY, 2022–2029 (USD MILLION)
TABLE 150 SOUTH KOREA: PERITONEAL DIALYSIS MARKET,
BY DISEASE INDICATION, 2022–2029 (USD MILLION)
TABLE 151 SOUTH KOREA: PERITONEAL DIALYSIS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 152 REST OF ASIA PACIFIC: PERITONEAL DIALYSIS MARKET,
BY OFFERING, 2022–2029 (USD MILLION)
TABLE 153 REST OF ASIA PACIFIC: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 154 REST OF ASIA PACIFIC: PERITONEAL DIALYSIS MARKET,
BY MODALITY, 2022–2029 (USD MILLION)
TABLE 155 REST OF ASIA PACIFIC: PERITONEAL DIALYSIS MARKET,
BY DISEASE INDICATION, 2022–2029 (USD MILLION)
TABLE 156 REST OF ASIA PACIFIC: PERITONEAL DIALYSIS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 157 LATIN AMERICA: PERITONEAL DIALYSIS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 158 LATIN AMERICA: PERITONEAL DIALYSIS MARKET,
BY OFFERING, 2022–2029 (USD MILLION)
TABLE 159 LATIN AMERICA: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 160 LATIN AMERICA: PERITONEAL DIALYSIS MARKET,
BY MODALITY, 2022–2029 (USD MILLION)
TABLE 161 LATIN AMERICA: PERITONEAL DIALYSIS MARKET,
BY DISEASE INDICATION, 2022–2029 (USD MILLION)
TABLE 162 LATIN AMERICA: PERITONEAL DIALYSIS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 163 BRAZIL: MACROECONOMIC INDICATORS
TABLE 164 BRAZIL: PERITONEAL DIALYSIS MARKET, BY OFFERING,
2022–2029 (USD MILLION)
TABLE 165 BRAZIL: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 166 BRAZIL: PERITONEAL DIALYSIS MARKET, BY MODALITY,
2022–2029 (USD MILLION)
TABLE 167 BRAZIL: PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION,
2022–2029 (USD MILLION)
TABLE 168 BRAZIL: PERITONEAL DIALYSIS MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 169 MEXICO: MACROECONOMIC INDICATORS
TABLE 170 MEXICO: PERITONEAL DIALYSIS MARKET, BY OFFERING,
2022–2029 (USD MILLION)
TABLE 171 MEXICO: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 172 MEXICO: PERITONEAL DIALYSIS MARKET,
BY MODALITY, 2022–2029 (USD MILLION)
TABLE 173 MEXICO: PERITONEAL DIALYSIS MARKET,
BY DISEASE INDICATION, 2022–2029 (USD MILLION)
TABLE 174 MEXICO: PERITONEAL DIALYSIS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 175 REST OF LATIN AMERICA: PERITONEAL DIALYSIS MARKET,
BY OFFERING, 2022–2029 (USD MILLION)
TABLE 176 REST OF LATIN AMERICA: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 177 REST OF LATIN AMERICA: PERITONEAL DIALYSIS MARKET,
BY MODALITY, 2022–2029 (USD MILLION)
TABLE 178 REST OF LATIN AMERICA: PERITONEAL DIALYSIS MARKET,
BY DISEASE INDICATION, 2022–2029 (USD MILLION)
TABLE 179 REST OF LATIN AMERICA: PERITONEAL DIALYSIS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 180 MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS MARKET,
BY OFFERING, 2022–2029 (USD MILLION)
TABLE 181 MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 182 MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS MARKET,
BY MODALITY, 2022–2029 (USD MILLION)
TABLE 183 MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS MARKET,
BY DISEASE INDICATION, 2022–2029 (USD MILLION)
TABLE 184 MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 185 GCC COUNTRIES: PERITONEAL DIALYSIS MARKET,
BY OFFERING, 2022–2029 (USD MILLION)
TABLE 186 GCC COUNTRIES: PERITONEAL DIALYSIS PRODUCTS MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 187 GCC COUNTRIES: PERITONEAL DIALYSIS MARKET,
BY MODALITY, 2022–2029 (USD MILLION)
TABLE 188 GCC COUNTRIES: PERITONEAL DIALYSIS MARKET,
BY DISEASE INDICATION, 2022–2029 (USD MILLION)
TABLE 189 GCC COUNTRIES: PERITONEAL DIALYSIS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 190 PERITONEAL DIALYSIS MARKET: DEGREE OF COMPETITION
TABLE 191 PERITONEAL DIALYSIS MARKET: OFFERING FOOTPRINT
TABLE 192 PERITONEAL DIALYSIS MARKET: MODALITY FOOTPRINT
TABLE 193 PERITONEAL DIALYSIS MARKET: DISEASE INDICATION FOOTPRINT
TABLE 194 PERITONEAL DIALYSIS MARKET: END-USER FOOTPRINT
TABLE 195 PERITONEAL DIALYSIS MARKET: REGION FOOTPRINT
TABLE 196 PERITONEAL DIALYSIS MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS
TABLE 197 PERITONEAL DIALYSIS MARKET: COMPETITIVE BENCHMARKING OF
KEY START-UP/SME PLAYERS REGION FOOTPRINT
TABLE 198 PERITONEAL DIALYSIS MARKET: PRODUCT APPROVALS
(JANUARY 2021- SEPTEMBER 2024)
TABLE 199 PERITONEAL DIALYSIS MARKET: DEALS, JANUARY 2020–SEPTEMBER 2024
TABLE 200 PERITONEAL DIALYSIS MARKET: EXPANSIONS, JANUARY 2020–SEPTEMBER 2024
TABLE 201 FRESENIUS MEDICAL CARE AG: COMPANY OVERVIEW
TABLE 202 FRESENIUS MEDICAL CARE AG: PRODUCTS & SERVICES OFFERED
TABLE 203 FRESENIUS MEDICAL CARE AG: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 204 BAXTER INTERNATIONAL INC.: COMPANY OVERVIEW
TABLE 205 BAXTER INTERNATIONAL INC.: PRODUCTS & SERVICES OFFERED
TABLE 206 BAXTER INTERNATIONAL INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 207 MEDTRONIC PLC: COMPANY OVERVIEW
TABLE 208 MEDTRONIC PLC: PRODUCTS & SERVICES OFFERED
TABLE 209 MEDTRONIC PLC: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 210 DAVITA INC.: COMPANY OVERVIEW
TABLE 211 DAVITA INC.: PRODUCTS & SERVICES OFFERED
TABLE 212 DAVITA INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 213 DAVITA INC.: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
TABLE 214 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
TABLE 215 BECTON, DICKINSON AND COMPANY: PRODUCTS & SERVICES OFFERED
TABLE 216 BECTON, DICKINSON AND COMPANY: EXPANSIONS,
JANUARY 2021–SEPTEMBER 2024
TABLE 217 TERUMO CORPORATION: COMPANY OVERVIEW
TABLE 218 TERUMO CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 219 TERUMO CORPORATION: PRODUCT APPROVALS,
JANUARY 2021–SEPTEMBER 2024
TABLE 220 TERUMO CORPORATION: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 221 TERUMO CORPORATION: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
TABLE 222 UTAH MEDICAL PRODUCTS, INC.: BUSINESS OVERVIEW
TABLE 223 UTAH MEDICAL PRODUCTS, INC.: PRODUCTS & SERVICES OFFERED
TABLE 224 DIAVERUM AB: COMPANY OVERVIEW
TABLE 225 DIAVERUM AB: PRODUCTS & SERVICES OFFERED
TABLE 226 MEDIONICS: BUSINESS OVERVIEW
TABLE 227 MEDIONICS: PRODUCTS & SERVICES OFFERED
TABLE 228 NEWSOL TECHNOLOGIES INC.: COMPANY OVERVIEW
TABLE 229 NEWSOL TECHNOLOGIES INC.: PRODUCTS & SERVICES OFFERED
TABLE 230 APOLLO DIALYSIS PVT. LTD.: BUSINESS OVERVIEW
TABLE 231 APOLLO DIALYSIS PVT. LTD.: PRODUCTS & SERVICES OFFERED
TABLE 232 U.S. RENAL CARE, INC.: BUSINESS OVERVIEW
TABLE 233 U.S. RENAL CARE, INC.: PRODUCTS & SERVICES OFFERED
TABLE 234 NORTHWEST KIDNEY CENTERS: COMPANY OVERVIEW
TABLE 235 NORTHWEST KIDNEY CENTERS: PRODUCTS & SERVICES OFFERED
TABLE 236 NORTHWEST KIDNEY CENTERS: DEALS, JANUARY 2021–SEPTEMBER 2024
TABLE 237 NORTHWEST KIDNEY CENTERS: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
TABLE 238 RELAVO: COMPANY OVERVIEW
TABLE 239 RELAVO: PRODUCTS & SERVICES OFFERED
TABLE 240 MITRA INDUSTRIES PVT. LTD.: BUSINESS OVERVIEW
TABLE 241 MITRA INDUSTRIES PVT. LTD.: PRODUCTS & SERVICES OFFERED
